LYSA-LYSARC 2025 Annual Report

The year 2025 was both productive and stimulating for LYSA-LYSARC, marked by major scientific achievements and challenges successfully addressed through collective effort. With 128 scientific outputs, including 38 publications and 90 conference presentations, LYSARC demonstrated its strong and tangible contribution to the scientific community.

Several highlights marked the year:

• A number of projects showcased the organization’s operational excellence, including the MorningLyte, INTENSIFY, DESCAR-T, and CLL18/MOIRAI studies.
• 2025 also provided an opportunity to celebrate LYSARC’s 25th anniversary, while highlighting its technical advances and the impact of its research programs.
• A continued commitment to innovation, illustrated by the integration of artificial intelligence into the BIDIFLY study and the implementation of innovative methodologies within the PlaTform study.

These major initiatives and ambitious projects made 2025 a year defined by dynamism and excellence. All of these scientific achievements were made possible through the dedication of our teams and the continued trust of our partners. Building on its accomplishments, LYSA-LYSARC remains committed to developing impactful and strategic projects each year, strengthening its foundations while helping to shape the future of lymphoma research.